These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Subthreshold diode micropulse laser versus observation in acute central serous chorioretinopathy. Arora S; Sridharan P; Arora T; Chhabra M; Ghosh B Clin Exp Optom; 2019 Jan; 102(1):79-85. PubMed ID: 30058731 [TBL] [Abstract][Full Text] [Related]
7. Randomized Clinical Trial to Compare Micropulse Photocoagulation Versus Half-dose Verteporfin Photodynamic Therapy in the Treatment of Central Serous Chorioretinopathy. Kretz FT; Beger I; Koch F; Nowomiejska K; Auffarth GU; Koss MJ Ophthalmic Surg Lasers Imaging Retina; 2015 Sep; 46(8):837-43. PubMed ID: 26431299 [TBL] [Abstract][Full Text] [Related]
8. Subthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathy. Koss MJ; Beger I; Koch FH Eye (Lond); 2012 Feb; 26(2):307-14. PubMed ID: 22079961 [TBL] [Abstract][Full Text] [Related]
9. Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage. Chen SN; Hwang JF; Tseng LF; Lin CJ Ophthalmology; 2008 Dec; 115(12):2229-34. PubMed ID: 19041477 [TBL] [Abstract][Full Text] [Related]
10. Nonvisible subthreshold micropulse diode laser (810 nm) treatment of central serous chorioretinopathy. A pilot study. Lanzetta P; Furlan F; Morgante L; Veritti D; Bandello F Eur J Ophthalmol; 2008; 18(6):934-40. PubMed ID: 18988165 [TBL] [Abstract][Full Text] [Related]
11. Half-dose photodynamic therapy followed by diode micropulse laser therapy as treatment for chronic central serous chorioretinopathy: evaluation of a prospective treatment protocol. Breukink MB; Mohr JK; Ossewaarde-van Norel A; den Hollander AI; Keunen JE; Hoyng CB; Boon CJ Acta Ophthalmol; 2016 Mar; 94(2):187-97. PubMed ID: 26670630 [TBL] [Abstract][Full Text] [Related]
12. Visual outcomes and anatomic changes after sub-threshold micropulse yellow laser (577-nm) treatment for chronic central serous chorioretinopathy: long-term follow-up. Arsan A; Kanar HS; Sonmez A Eye (Lond); 2018 Apr; 32(4):726-733. PubMed ID: 29303148 [TBL] [Abstract][Full Text] [Related]
13. COMPARISON OF PHOTODYNAMIC THERAPY USING HALF-DOSE OF VERTEPORFIN OR HALF-FLUENCE OF LASER LIGHT FOR THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY. Cheng CK; Chang CK; Peng CH Retina; 2017 Feb; 37(2):325-333. PubMed ID: 27429374 [TBL] [Abstract][Full Text] [Related]
14. Micropulse diode laser treatment for chronic central serous chorioretinopathy: a randomized pilot trial. Roisman L; Magalhães FP; Lavinsky D; Moraes N; Hirai FE; Cardillo JA; Farah ME Ophthalmic Surg Lasers Imaging Retina; 2013; 44(5):465-70. PubMed ID: 24044709 [TBL] [Abstract][Full Text] [Related]
15. Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy. Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Kneba M; Grzybowski A BMC Ophthalmol; 2019 Jul; 19(1):160. PubMed ID: 31345183 [TBL] [Abstract][Full Text] [Related]
16. The efficacy of subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy. Uzlu D; Erdöl H; Kola M; Özbay AD Lasers Med Sci; 2021 Jul; 36(5):981-988. PubMed ID: 32812130 [TBL] [Abstract][Full Text] [Related]
17. Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation. Vujosevic S; Bottega E; Casciano M; Pilotto E; Convento E; Midena E Retina; 2010 Jun; 30(6):908-16. PubMed ID: 20168272 [TBL] [Abstract][Full Text] [Related]
18. Nondamaging photothermal therapy for the retina: initial clinical experience with chronic central serous retinopathy. Lavinsky D; Palanker D Retina; 2015 Feb; 35(2):213-22. PubMed ID: 25158944 [TBL] [Abstract][Full Text] [Related]
19. Short-duration multiple-session subthreshold micropulse yellow laser (577 nm) for chronic central serous chorioretinopathy: results at 3 years. Kim YJ; Kim SY; Ha S; Moon D; Seong S; Kwon OW; Park HS Eye (Lond); 2019 May; 33(5):819-825. PubMed ID: 30610228 [TBL] [Abstract][Full Text] [Related]